RGEN : Summary for Repligen Corporation - Yahoo Finance

U.S. Markets close in 2 hrs 15 mins

Repligen Corporation (RGEN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
34.51-0.13 (-0.38%)
As of 1:44PM EDT. Market open.
People also watch
SGMOSCLNNBIXPGNXLGND
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close34.64
Open34.16
Bid34.54 x 100
Ask34.60 x 100
Day's Range33.38 - 34.71
52 Week Range21.11 - 35.61
Volume55,830
Avg. Volume225,096
Market Cap1.17B
Beta1.20
PE Ratio (TTM)101.50
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Stocks Flat But Alphabet, Lockheed Martin Hit New Highs
    Investor's Business Daily10 days ago

    Stocks Flat But Alphabet, Lockheed Martin Hit New Highs

    The stock market was barely higher, although Alphabet and Lockheed Martin made record highs amid the trendless trading.

  • Investopedia26 days ago

    Top 3 Healthcare Penny Stocks for 2017

    These three penny health care stocks are poised for a positiv 2017.

  • Repligen Corp. :RGEN-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017
    Capital Cubelast month

    Repligen Corp. :RGEN-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017

    Categories: Yahoo Finance Get free summary analysis Repligen Corp. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Repligen Corp. – Neurocrine Biosciences, Inc., General Electric Company, Thermo Fisher Scientific Inc., Pfizer Inc., Charles River Laboratories International, Inc. and Bristol-Myers Squibb Company (NBIX-US, GE-US, TMO-US, PFE-US, CRL-US ... Read more (Read more...)